Attached files
file | filename |
---|---|
8-K - WaferGen Bio-systems, Inc. | v207860_8k.htm |
Exhibit
99.1
January
7, 2011
|
Contact:
|
FOR
IMMEDIATE RELEASE
|
Don
Huffman, CFO
|
don.huffman@wafergen.com
|
|
Joyce
Strand
|
|
Joyce.strand@wafergen.com
|
|
510-651-4450
|
WaferGen
to Present at OneMedForum San Francisco 2011
Fremont, Calif., January 7,
2011 – WaferGen Biosystems, Inc. (OTCBB:WGBS), a leading developer of
state-of-the-art genomic analysis systems, today announced that it will present
an overview of the company at the 4th Annual OneMedForum Business Development
and Investment Conference for emerging healthcare and life science companies
held concurrently with the JP Morgan Healthcare Conference in San Francisco,
January 11-13, 2011.
The
presentation will occur at the Sir Francis Drake Hotel in San Francisco on
Wednesday, January 12, 2011 at 2:30 p.m. Pacific time. It will be
Webcast live and may be accessed at www.wafergen.com; and it will be archived
for 90 days.
About
WaferGen and the SmartChip Real-Time PCR System
WaferGen
Biosystems, Inc. is a leader in the development, manufacture and sale of
state-of-the-art systems for genomic analysis for the life science and
pharmaceutical industries. The company currently offers the
breakthrough SmartChip Real-Time PCR system, the next-generation Real-Time PCR
system for discovery and validation of biomarkers, or gene expression patterns,
on a single platform. The company believes that the SmartChip system is ideal
for researchers seeking to confirm discoveries made with the growing use of
next-generation sequencing. In addition, the high throughput
capabilities of the SmartChip system enable scientists to extend their research
across large panels of genes, and hundreds of samples, at a reasonable
cost.
In
addition, the company offers an innovative fee-based service for gene-expression
profiling using the SmartChip system. For additional information,
please see http://www.wafergen.com.
# #
#